StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
Check Out Our Latest Stock Analysis on SNES
SenesTech Stock Down 2.1 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Does Downgrade Mean in Investing?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Calculate Options Profits
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.